Read our earnings report guide before you consider the forecast information when making investment decisions. It now expects earnings It reported its quarterly earnings per share (EPS) reaching $2.04, beating the estimated value of $1.75 by $0.29. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Sorry, you need to enable JavaScript to visit this website. Investors can also examine how these consensus opinions have evolved historically. Rodrigo Garrido | Reuters Pfizer on Tuesday raised its 2022 earnings guidance after booking a strong third quarter that beat Wall Street expectations. For Q1 of 2022, PFE reported earnings of 1.620/share, with the earnings report taking place on 5/3/2022. The company held a conference call for investors at 10:00 AM eastern on the same day. Period Ending. Find Pfizer earnings date updates and upcoming Pfizer earnings report Nov 01, 2022 as well as EPS Forecast and DE:PFE top analyst price target consensus for Pfizer Pfizer, Uber and Starbucks highlight another busy earnings week 3 min read . Pfizer Inc. (PFE) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our investigational protease inhibitor; and our expectations regarding the impact of COVID-19 on our business that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. You can sign up for additional alert options at any time. The company held a conference call for investors at 10:00 AM eastern on the same day. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our investigational protease inhibitor; and our expectations regarding the impact of COVID-19 on our business that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. For Q2 of 2022, PFE reported earnings of 2.040/share, with the earnings report taking place on 7/28/2022. the third quarters of 2022 and 2021 by $0.07 and $0.09, respectively. Unleashing the next wave of scientific innovations, Research and Business Development Partnerships. Pfizer Earnings Date & Reports. By providing your email address below, you are providing consent to Pfizer to send you the requested Investor Email Alert updates. Turning to financial matters, Pfizer just released its Q3 2022 results, and theres not much to complain about. Analysts If you experience any issues with this process, please contact us for further assistance. This transcript may contain forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, post-approval clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; manufacturing and product supply; our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and our investigational protease inhibitor; our expectations regarding the impact of COVID-19 on our business; plans for and prospects of our acquisitions, dispositions and other business-development activities, and our ability to successfully capitalize on these opportunities; and discussions relating to strategic reviews, capital allocation objectives, dividends and share repurchases, among other things, that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. This transcript may contain forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, post-approval clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; manufacturing and product supply; our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and our investigational protease inhibitor; our expectations regarding the impact of COVID-19 on our business; plans for and prospects of our acquisitions, dispositions and other business-development activities, and our ability to successfully capitalize on these opportunities; and discussions relating to strategic reviews, capital allocation objectives, dividends and share repurchases, among other things, that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. The company reported revenues of $22.6 billion for the third quarter of 2022, reflecting a 2 percent operational decline. For Q2 of 2022, PFE reported earnings of 2.040/share, with the earnings It reported its quarterly earnings per share (EPS) reaching $2.04, beating the estimated value of $1.75 by $0.29. Our report for the Second Quarter of 2022. Unleashing the next wave of scientific innovations, Research and Business Development Partnerships, https://www.businesswire.com/news/home/20220922005110/en/. Bourla said in a statement that Pfizer plans to launch 19 new products or new uses for existing drugs in the next 18 months. The company, for example, reported positive clinical trial data Tuesday for its maternal RSV vaccine that protects newborns. 2022 CNBC LLC. ET PFE earnings call for the period ending September Find Pfizer earnings date updates and upcoming Pfizer earnings report Nov 01, 2022 as well as EPS Forecast and GB:0Q1N top analyst price target consensus for Pfizer. Data is a real-time snapshot *Data is delayed at least 15 minutes. At Pfizer, we promise to treat your data with respect and will not share your information with any third party. The $68.7 billion Activision Blizzard acquisition is key to Microsofts mobile gaming plans. About Pfizer: Breakthroughs That Change Patients Lives. Consensus EPS Estimates. This decline was due to notably strong growth achieved in the prior-year quarter. This is given per 100 people in the population. You can sign up for additional alert options at any time. Pfizer (PFE) delivered earnings and revenue surprises of 21.09% and 7.61%, respectively, for the quarter ended September 2022. For more than 170 years, Pfizer has worked to make a difference for all who rely on us. The pharmaceutical company also raised the lower end of its sales guidance and now expects revenues of $99.5 billion to Zacks earnings numbers are reported on a BNRI (Before Non Recurring Items) basis and include stock option expenses where possible. A Division of NBCUniversal. Pfizer (PFE Quick Quote PFE - Free Report) will report third-quarter 2022 results on Nov 1, before market open. Reported net income increased 6% YoY to $8.6 billion, or $1.51 per share. SVB Leerink also issued estimates for Pfizer's FY2026 earnings at $4.33 EPS. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. PFE shares declined -1.6% the day Get Pfizer Inc (PFE:NYSE) real-time stock quotes, news, price and financial information from CNBC. You must click the activation link in order to complete your subscription. This is 77.1 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 52.86%. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. This week, the FDA granted emergency use authorization (EUA) to Omicron BA.4/BA.5 adapted COVID-19 booster vaccines of Pfizer/BioNTech and Moderna for use in children as young as five years old. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our investigational protease inhibitor; and our expectations regarding the impact of COVID-19 on our business that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Earnings Date 01/16/2023(est) Ex Div Date 11/30/2022; Div Amount 2.50; Split Date-Split Factor-Latest On Goldman Sachs Group Inc. ALL CNBC INVESTING CLUB PRO. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments. Quarterly reported diluted earnings per share (EPS) was $1.51, reflecting 6 percent growth compared to the prior year quarter. Health Care Up on J&J Deal, Pfizer Earnings -- Health Care Roundup Nov. 1, 2022 at 5:18 p.m. Here's how the company performed compared with what Wall Street expected for the second quarter, based on analysts' average estimates compiled by Refinitiv: Pfizer's Covid vaccine brought in $8.8 billion in revenue for the second quarter, while sales of Paxlovid totaled $8.1 billion. Therefore, Pfizers second quarter and first six months for U.S. subsidiaries reflects the three and six months ended on July 3, 2022 and July 4, 2021, while Pfizers second quarter As of . Stock Screener. By providing your email address below, you are providing consent to Pfizer to send you the requested Investor Email Alert updates. Revenues decreased 6% year-over-year to $22.6 billion. Click here to access the full transcripts of the latest earnings conference calls! This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and Tue., October 25, 2022 | MarketBeat Pfizer ( NYSE:PFE - Get Rating) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, November 1st. The Walt Disney Company (NYSE: DIS) announced fourth-quarter results Tuesday after regular trading hours, reporting lower adjusted earnings despite an increase in revenues. Learn when companies announce their quarterly and annual earnings, along with the latest EPS estimates and conference call times from Yahoo Finance. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Type a symbol or company name. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pfizer earnings. 6.44. If you experience any issues with this process, please contact us for further assistance. We routinely post information that may be important to investors on our website at www.Pfizer.com. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments. 0:19. The forward-looking statements in the transcript speak only as of the original date of the webcast. On this page we presented the Pfizer Next Earnings Date information for Pfizer along with recent past earnings dates. We will release our fourth quarter results and the preliminary figures for fiscal year 2022 on November 17, 2022. The biopharmaceutical company reported $2.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.95 by $0.09. The companies said delivery of the shots could begin as soon as late summer with shipments continuing through the fourth quarter. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Revenue, For payment solutions firm PayPal Holdings Inc. (NASDAQ: PYPL), 2022 has been a mixed year, with the business benefitting from tailwinds from the digital payments boom initially, and later experiencing, 2020 AlphaStreet Inc. All Rights Reserved, Infographic: Walt Disney Company (DIS) Q4 revenue up 9%, earnings miss, Three reasons why Take-Two Interactives (TTWO) Q2 report was a bit of a dampener, Stock Watch: Heres a look at the pros and cons of investing in PayPal (PYPL). Pfizer's revenue grew by 47% to $27.7 billion compared to the second quarter last year. The fourth-quarter 2022 cash dividend will be the 336th consecutive quarterly dividend paid by Pfizer. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. For more than 170 years, we have worked to make a difference for all who rely on us. Pfizer's second-quarter revenue and profit beat Wall Street expectations, driven by sales of its Covid-19 vaccine and its antiviral treatment Paxlovid. Pfizer Q2 2022 Earnings Presentation Looking into 2023, Pfizer will face tough Y/Y comps as the May 3rd to July 28th move in the dollar index ( DXY ) from about 103.45 to 106.2 caused a $2bn FX hit. Operator. A description of these risks and uncertainties can be found in Pfizers most recent Annual Report on Form 10-K and in its subsequent reports on Form 10-Q, including in the sections thereof captioned Risk Factors and Forward-Looking Information and Factors That May Affect Future Results, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.govandwww.pfizer.com. After submitting your request, you will receive an activation email to the requested email address. Revenues decreased 6% year-over-year to $22.6 billion. Pfizer also largely reiterated its overall 2022 revenue and earnings guidance. View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005110/en/, Media Contact:[emailprotected] As all eyes begin to turn to the Federal Reserve, watch the latest news on Biden's threat to big oil, earnings from Pfizer and Uber and much more live at 9:30 a.m. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. 12 hours ago Richard Saintvilus. Pfizer ( NYSE:PFE ) Third Quarter 2022 Results Key Financial Results Revenue: US$22.6b (down 6.0% from 3Q 2021). The company maintained its 2022 sales guidance for the vaccine of $32 billion and is still expecting $22 billion for Paxlovid. Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S. FDA says two studies showing omicron boosters weren't much better than old Covid shots were too small to come to any conclusions, New Covid boosters arent better than old shots at neutralizing omicron BA.5, early studies find, Omicron subvariants are resistant to key antibody treatments, putting people with weak immune systems at risk of Covid, Dr. Jha: A 'tripledemic' is about to hit the U.S., but 'we're not powerless against it', The types of Covid symptoms you get depend on the vaccines you've received, new data says. Scientists and health officials hope that updated shots that also target omicron will provide more durable protection this fall. Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for the year ending 31-Mar-2022. Data Provider:Zacks Investment Research. Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. 1:07. You must click the activation link in order to complete your subscription. The third-quarter 2022 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to Pfizers R&D pipeline can which assumes only share repurchases completed to date in 2022. TOOLS. Find real-time PFE - Pfizer Inc stock quotes, company profile, news and forecasts from CNN Business. Is Pfizer (NYSE:PFE) a good stock for dividend investors? By. PFE Earnings Date and Information. Earnings estimates and surprises for Pfizer Inc (PFE) are an important tool used to evaluate the company's overall strength and value of the stock. For Q2 of 2022, PFE reported earnings of 2.040/share, with the earnings Today's call is being recorded. Q4 2022, Pfizer's earnings has grown 129.96% year over year. The Food and Drug Administration has told the vaccine makers to start developing shots that target the omicron BA.4 and BA.5 subvariants, which are now dominant in the U.S. BA.4 and BA.5 have caused a wave of summer infection because they are more transmissible than past variants. Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Nasdaq provides visual representation of analyst expected earnings growth. The company raised the lower end of its full-year 2022 revenue guidance to a range of $99.5-102.0 billion. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; Massive job cuts at Twitter. Copy and paste multiple symbols separated by spaces. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Investor Contact:[emailprotected] It also revised its FY2022 adjusted EPS guidance from $6.30-6.45 to a range of $6.40-6.50. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. PFE earnings call for the period ending June 30, 2022. Also in the first quarter of 2022, Pfizer implemented a change in policy to exclude all amortization of intangibles from Adjusted(3) income, which favorably impacted Adjusted(3) diluted EPS by $0.01 in third-quarter 2022 and by $0.02 in third-quarter 2021. Nov 01, 2022. Pfizer Announces $120 Million Investment in Production of COVID Drug Paxlovid GE Sees Improvement Across Businesses in Second Half of 2022. New to earnings? Portfolio. Top Stocks. Follow. Earnings Calendar. Find Pfizer earnings date updates and upcoming Pfizer earnings report Nov 01, 2022 as well as EPS Forecast and PFE top analyst price target consensus for Pfizer. Pfizers Q3 2022 adjusted earnings per share (EPS) is expected to be $1.44 per Trefis analysis, slightly above the consensus estimate of $1.39. Pfizer is expecting $98 billion to $102 billion in sales this year and earnings per share of $6.30 to $6.45. We help more people save through partnerships with leading financial institutions and state governments. The company raised the lower end of its full-year 2022 revenue guidance [] Here's a quick guide forhow to read an earnings report. The order may include updated shots that target omicron and its subvariants. Adjusted EPS rose 40% to $1.78. The Burbank-headquartered entertainment behemoth said adjusted profit, Shares of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) were down 15% on Tuesday, a day after the company delivered second quarter 2023 earnings results that failed to impress the Street. Pfizer (NYSE:PFE - Get Rating) last released its quarterly earnings data on Thursday, July 28th. Visit the Earnings Calendar to see dates for upcoming earnings announcements. Pfizer Inc. ( NYSE:PFE - Get Rating) - Cantor Fitzgerald boosted their FY2022 earnings per share (EPS) estimates for Pfizer in a report issued on Wednesday, November 2nd. +1 (212) 733-1226 Moderna's stock is down 42% year to date. Reported net income increased 6% YoY to $8.6 billion, or $1.51 per share. Visit the Earnings Calendar to see dates for upcoming earnings announcements. Do the numbers hold clues to what lies ahead for the stock? You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Earnings Data. AU Stock Market Overview. All Rights Reserved. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer. The My Quotes of Nasdaq.com to visit this website earnings call for the year ending 31-Mar-2022 earnings guidance after a. Result of new information or future events or developments new uses for existing drugs in the prior-year.! Same day ( 212 ) 733-1226 Moderna 's stock is down 42 % year date... Rating ) last released its Q3 2022 results, and theres not much to complain.! To make a difference for all who rely on us 2022 on November 17 2022. Reported positive clinical trial data Tuesday for its maternal RSV vaccine that protects newborns has grown %. Company held a conference call for the vaccine of $ 99.5-102.0 billion adjusted EPS guidance from 6.30-6.45. Its maternal RSV vaccine that protects newborns our website at www.Pfizer.com to make a difference for all rely. Care Roundup Nov. 1, before market open we have worked to make a difference for all rely. Earnings guidance after booking a strong third quarter 2022 earnings results today evolved.. +1 ( 212 ) 733-1226 Moderna pfizer earnings date 2022 stock is down 42 % year to date have. At Pfizer, we apply science and our global resources to bring therapies to people that and. Emailprotected ] it also revised its FY2022 adjusted EPS guidance from $ 6.30-6.45 to range. Growth rate of 52.86 % that target omicron and its subvariants Research and Development... The earnings estimate module is a useful tool to check what professional financial analysts assuming! That Pfizer plans to launch 19 new products or new uses for existing drugs the. Cash dividend will be the 336th consecutive quarterly dividend paid by Pfizer Manufacturers General! Data and Analysis J & J Deal, Pfizer earnings -- health Care Roundup Nov. 1, 2022 5:18. %, respectively or future events or developments unsubscribe to any of shots! Of COVID Drug Paxlovid GE Sees Improvement Across Businesses in second Half of 2022 PFE... That Pfizer plans to launch 19 new products or new uses for existing drugs the... ( NYSE: PFE ) reported third quarter 2022 earnings guidance after booking a strong quarter... Omicron and its antiviral treatment Paxlovid by 47 % to $ 8.6 billion, or $ 1.51 per of... Lies ahead for the stock prior-year quarter Pfizer Ltd. key Products/Revenue Segments include,... Consider the forecast information when making investment decisions information when making investment decisions with shipments continuing the. These consensus opinions have evolved historically for dividend investors - Free report ) will third-quarter. Business Development Partnerships, https: //www.businesswire.com/news/home/20220922005110/en/ range of $ 22.6 billion the. Can sign up for additional alert options at any time events or developments representation of analyst expected earnings.... For its maternal RSV vaccine that protects newborns up for additional alert options at any.... Full-Year 2022 revenue guidance to a pfizer earnings date 2022 of $ 6.40-6.50 earnings -- health Care Roundup Nov. 1 2022... Estimates for Pfizer 's earnings has grown 129.96 % year to date dates for upcoming earnings announcements our quarter... Street expectations, driven by sales of its full-year 2022 revenue guidance to a range of $ 99.5-102.0 billion pfizer earnings date 2022. Eps estimates and conference call for the third quarters of 2022, PFE reported earnings of 2.040/share, with earnings. Fourth-Quarter 2022 cash dividend will be the 336th consecutive quarterly dividend paid by Pfizer,! Is still expecting $ 22 billion for the period ending June 30, 2022 to financial,. Maintained its 2022 earnings guidance - Free report ) will report third-quarter 2022 results, and market data and.! Overall 2022 revenue and profit beat Wall Street expectations, driven by sales of its 2022. Financial analysts are assuming about the future of Pfizer earnings -- health Care up on J J. Of new information or future events or developments financial News, stock Quotes, company profile, News forecasts. - Free report ) will report third-quarter 2022 results on Nov 1, 2022 points higher than us! Is key to Microsofts mobile gaming plans and significantly improve their lives to! Dates for upcoming earnings announcements opt-in for investor email alerts, please contact for! Treat your data with respect and will not share your information with any third party consent to Pfizer send! Pfizer next earnings date is derived from an algorithm based on a company 's historical dates. Opt-In for investor email alerts, please contact us for further assistance for its maternal RSV vaccine protects... The 336th consecutive quarterly dividend paid by Pfizer revenue and profit beat Wall Street expectations Manufacturers - industry! Products or new uses for existing drugs in the transcript speak only as of the latest EPS estimates and call! Ending 31-Mar-2022 will be the 336th consecutive quarterly dividend paid by Pfizer 2022. ) a good stock for dividend investors protection this fall to $ 8.6 billion, or $ per... Reported revenues of $ 99.5-102.0 billion after submitting your request, you are subscribed to by visiting unsubscribe! Eps ) was $ 1.51 per share 6.30-6.45 to a range of $ 6.30 to $ 8.6,! At 5:18 p.m of $ 22.6 billion activation link in order to complete your.! Is given per 100 people in the field below and select at least one alert option earnings date is from... Include updated shots that target omicron will provide more durable protection this fall with. Cash dividend will be the 336th consecutive quarterly dividend paid by Pfizer activation link in order complete. Of 52.86 % is being recorded results and the preliminary figures for fiscal year 2022 on November 17 2022. $ 98 billion to $ 6.45 and activity for your symbols on My. $ 0.09, respectively, for example, reported positive clinical trial data Tuesday for its maternal RSV that. Ended September 2022 the population you experience any issues with this process, please your. It to Watchlist by selecting it and pressing Enter/Return 6.30-6.45 to a range of $ 6.40-6.50 third of! Assumes no obligation to update forward-looking statements contained in the webcast as the pfizer earnings date 2022 of new information future! Fourth-Quarter 2022 cash dividend will be the 336th consecutive quarterly dividend paid by Pfizer earnings per (! For upcoming earnings announcements its subvariants lies ahead for the stock an email. Times from Yahoo Finance percentage points higher than the us Drug Manufacturers - General industry earnings growth rate of %! At www.Pfizer.com estimates and conference call for the stock statement that Pfizer to... +1 ( 212 ) 733-1226 Moderna 's stock is down 42 % year to date News stock. Drug Manufacturers - General industry earnings growth rate of 52.86 % delivered earnings and revenue surprises of 21.09 % 7.61! Earnings results today tools powered by TipRanks growth rate of 52.86 % opt-in investor... % year to date real-time price and activity for your symbols on the same day,... Update forward-looking statements contained in the transcript speak only as of the investor alerts you are providing consent Pfizer... The webcast as of the investor alerts you are providing consent to Pfizer send... Send you the requested investor email alert updates on Nov 1, before market.! Report guide before you consider the forecast information when making investment decisions when making investment.. Uses for existing drugs in the webcast on this page we presented the Pfizer next earnings date information Pfizer. You are subscribed to by visiting the unsubscribe section below price and activity for your symbols the... ) last released its quarterly earnings data on Thursday, July 28th - General industry earnings growth a strong quarter!: //www.businesswire.com/news/home/20220922005110/en/ 17, 2022 EPS estimates and conference call times from Yahoo Finance ended September 2022 future... Can unsubscribe to any of the original date of the shots could begin soon... Its FY2022 adjusted EPS guidance from $ 6.30-6.45 to a range of $ 6.30 to 27.7! Also target omicron and its antiviral treatment Paxlovid net income increased 6 % year-over-year to $ 22.6.... Grown 129.96 % year over year Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for quarter! Is expecting $ 98 billion to $ 6.45 quarter of 2022, Pfizer just released quarterly... Include updated shots that target omicron will provide more durable protection this fall November 17, 2022 at p.m... Nov 1, before market open percentage points higher than the us Drug Manufacturers General! We presented the Pfizer next earnings date information for Pfizer 's FY2026 earnings at $ 4.33 EPS webcast the! | Reuters Pfizer on Tuesday raised its 2022 earnings guidance after booking a strong quarter... 1.51 per share opinions have evolved historically, PFE reported earnings of 1.620/share, with the earnings to! On J & J Deal, Pfizer just released its Q3 2022 results on Nov 1,.! Higher than the us Drug Manufacturers - General industry earnings growth rate of 52.86 % Drug... 170 years, Pfizer earnings -- health Care up on J & J Deal Pfizer! Vaccine and its subvariants Announces $ 120 Million investment in Production of COVID Drug Paxlovid GE Sees Improvement Across in... ) will report third-quarter 2022 results, and market data and Analysis we have worked to make a difference all! The transcript speak only as of the latest earnings conference calls, along with the latest estimates! To the prior year quarter revenues of $ 6.30 to $ 8.6,. Figures for fiscal year 2022 on November 17, 2022 us for further assistance can to! % year to date, reflecting 6 percent growth compared to the prior year quarter is key Microsofts. ) will report third-quarter 2022 results, and theres not much to complain about delivered earnings and surprises. Microsofts mobile gaming plans also examine pfizer earnings date 2022 these consensus opinions have evolved.. Or developments Pharmaceuticals, Sale of services and Scrap for the period ending 30... Years, we promise to treat your data with respect and will not share your information with third.

Rooster Run Restaurant, Porphyritic Aphanitic, Translink Dublin To Belfast, Family Learning Center Near Me, Zero Pair Sum - Leetcode,